Analysts estimate that Chemed will report an earnings per share (EPS) of $4.72.
Chemed bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
Earnings Track Record
In the previous earnings release, the company beat EPS by $0.08, leading to a 6.61% drop in the share price the following trading session.
Here's a look at Chemed's past performance and the resulting price change:
Quarter
Q1 2025
Q4 2024
Q3 2024
Q2 2024
EPS Estimate
5.55
6.78
5.76
5.59
EPS Actual
5.63
6.83
5.64
5.47
Price Change %
-7.000000000000001%
7.000000000000001%
-12.0%
-1.0%
Tracking Chemed's Stock Performance
Shares of Chemed were trading at $470.72 as of July 25. Over the last 52-week period, shares are down 17.79%. Given that these returns are generally negative, long-term shareholders are likely unhappy going into this earnings release.
Insights Shared by Analysts on Chemed
Understanding market sentiments and expectations within the industry is crucial for investors. This analysis delves into the latest insights on Chemed.
The consensus rating for Chemed is Buy, based on 3 analyst ...
